IPO Issue Details
Issue Price / Price Band₹114 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size128 Shares per Lot
Total Issue Size2,20,00,000 shares (aggregating up to ₹[.] Cr
Issue TypeBook Built Issue
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 22 Dec 2025
Subscription CloseWed, 24 Dec 2025
Anchor AllotmentFri, 19 Dec 2025
Basis of AllotmentFri, 26 Dec 2025
Initiation of RefundsMon, 29 Dec 2025
Credit of Shares to DematMon, 29 Dec 2025
Listing DateTue, 30 Dec 2025
UPI Mandate Deadline2025-12-24
Application & Investment Details
Retail — Min (1 Lots)₹14,592 — 128 shares
Retail — Max (13 Lots)₹189,696 (13 Lots)
HNI — Min (69 Lots)₹10,06,848 — 8,832 shares
EPS (Pre-IPO)₹1.85
EPS (Post-IPO)₹2.74
P/E Ratio (Pre-IPO)61.62x
P/E Ratio (Post-IPO)41.59x
Pre-IPO Promoter Holding5,68,43,250 shares
Post-IPO Promoter Holding7,88,43,250 shares
About Gujarat Kidney & Super Speciality Ltd.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).Services:Secondary Care Services: General and surgical treatments. Tertiary Care Services: Super speciality surgical procedures. Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.Competitive Strengths:Pre-eminence in renal sciences, with established sub-superspecialities in urologyAsset light business model with focus in central region of GujaratAbility to attract, retain skilled and experienced quality medical professionalsTrack record of operating and financial performance and growth
Objects of the Issue
Gujarat Kidney & Super Speciality Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Proposed acquisition of Parekhs Hospital at Ahmedabad.
77.00
2
Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”.
12.40
3
Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.
30.10
4
Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.
6.83
5
Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company
1.20
6
Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.
7
Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch
10.78
Shareholding & Lock-in
Pre-IPO Promoter Holding
5,68,43,250 shares
Post-IPO Promoter Holding
7,88,43,250 shares
Lock-in Period (30%)Sun, Jan 25, 2026
Lock-in Period (50%)Thu, Mar 26, 2026